Abstract
The clinicopathological characteristics of breast cancer in 95 women between the ages of 24 and 45 years with a family history of breast cancer were compared with tumours from 329 women with sporadic disease matched for age and year of diagnosis. There was a trend for the family history patients to have slightly smaller tumours (mean size 2.49 cm) than the controls (mean 3.04 cm) (Mann-Whitney test, P = 0.09). A significantly greater proportion of the familial cases had grade III infiltrating ductal carcinoma than did the controls (40% vs 27%; chi2(1) = 5.64, P = 0.02). Despite this, there were more cases of operable node-negative disease among the study group than among the controls (48% vs 32%; chi2(1) = 8.2, P = 0.004). There was a highly significant survival advantage for patients with a family history (chi2 = 22.4, P < 0.001). Five- and 10-year survival rates were 92% and 87% for those with a family history compared with 70% and 54% for those in the control group. This survival advantage was maintained when patients with operable disease only were considered. In multivariate analysis, which included age, tumour size, stage, histological grade and family history, family history was an independent predictor of favourable pro...Continue Reading
Citations
May 6, 2004·The Breast Journal·Takayuki KinoshitaSadako Akashi-Tanaka
May 27, 2004·British Journal of Cancer·A MolinoG L Cetto
Jan 13, 2006·British Journal of Cancer·H M VerkooijenC Bouchardy
Oct 8, 2013·Familial Cancer·Meghan J WalkerAnna M Chiarelli
Jan 30, 2016·European Journal of Public Health·Mattea OrsiniFaiza Bessaoud
Feb 9, 2017·Familial Cancer·Jun-Long SongSheng-Rong Sun
Dec 13, 2017·Oncotarget·Yansu WangChaosu Hu
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Antonio RussoGaetano Cardona
Jul 22, 2006·Familial Cancer·Sara MargolinTommy Fornander
Jan 23, 2016·Cancer Medicine·Jennifer C MelvinMieke Van Hemelrijck
Apr 1, 2004·British Journal of Cancer·L ThalibP Hall
Sep 15, 2012·Experimental and Therapeutic Medicine·A-Yong CaoZhi-Ming Shao
Sep 25, 2015·Acta Oncologica·Jan J JobsenHenk Struikmans
Jul 29, 2017·Cancer Causes & Control : CCC·Anne-Sophie JannotElisabetta Rapiti
Jun 22, 2020·The Breast Journal·Amir Shahram Yousefi Kashi
Mar 4, 1999·Histopathology·D M Barnes
Jul 4, 2001·International Journal of Cancer. Journal International Du Cancer·H EerolaR Sankila
May 21, 2015·The British Journal of Surgery·B K EcclesUNKNOWN POSH Study Steering Group
Mar 16, 2001·Breast Cancer Research : BCR·P P Osin, S R Lakhani
Nov 23, 2006·Breast Cancer Research and Treatment·Jane C FigueiredoPamela J Goodwin
Oct 1, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kathleen E MalonePeggy L Porter
Sep 10, 2020·Heliyon·Samah Isam Abdalla Elhassan
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·R P R GroenendijkTh Wobbes
Aug 3, 2021·EClinicalMedicine·Yaqian XuJinsong Lu